Maryam Abaei1, Sjoerd B. Vos2,3, Derek L.G. Hill1, Robin Wolz1,4, Marios C Yiannakas5, Magdalena Sokolska6, Sebastien Ourselin2,7, John Duncan2,8, and David Thomas9,10
1IXICO PLC, London, United Kingdom, 2Translational Imaging Group, CMIC, University College London, London, United Kingdom, 3Epilepsy Society MRI Unit, Chalfont St Pete, United Kingdom, 4Department of Computing, Imperial College, London, United Kingdom, 5UCL Institute of Neurology, University College London, London, London, United Kingdom, 6Department of Medical Physics and Bioengineering, University College Hospital, London, United Kingdom, 7Dementia Research Centre, University College London, London, United Kingdom, 8Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, Chalfont St Peter, United Kingdom, 9Brain Repair & Rehabilitation, UCL Institute of Neurology, London, United Kingdom, 10Leonard Wolfson Experimental Neurology Centre, UCL Institute of Neurology, London, United Kingdom
Synopsis
Multi-centre, MRI, Susceptibility Weighted imaging, Brain, Clinical Studies
Introduction
Susceptibility Weighted Imaging (SWI) has
reached a level that allows its application in multiple clinical and research
applications for the visualization of small veins and quantification of iron/calcium
deposits1. The strong contrast and
non-invasive nature of SWI have made it an attractive alternative to less sensitive conventional sequences. Implementations
of SWI are commercially available on all major MRI systems and the number of
clinical applications is continuously growing in neurodegenerative disease such
as Alzheimer’s disease. Previous studies showed that single-echo SWI is useful
in the visualization, but
not the quantification of perturbations to B02. Compared to single echo images, multi-echo images have increased
SNR and CNR, and consequently improved visibility of small venous3. However, one
obstacle that impedes longitudinal clinical and research applications of SWI is
the differences in the commercial implementations of SWI from the major MRI
vendors. One recently published study
investigated the reproducibility and consistency of QSM within healthy adult
subjects among multiple sites and reported regional dependency of QSM within
and across sites4.
Aim
The aim of this study was to
evaluate and compare inter-vendor reproducibility of product SWI sequences as
clinically implemented by Siemens,
Philips and GE.Materials and Methods
Three healthy volunteers (1 Male and 2 Female,
mean age 36 (±8) years) were included. All subjects were scanned at
: (1) GE MR750 (software version DV24_R02);
(2) Philips Achieva (software version 5.1.0.2); (3) Siemens Prisma (software
version VE11C). Each scan session included the vendor’s product 3D SWI (Table 1),
a 3D T1-weighted MPRAGE scan for segmentation and registration purposes and a
3D multi-echo T2*-weighted scan.
For each subject, MPRAGE images were
segmented and regional labels estimated using a joint multi-atlas and Gaussian
mixture model method (GIF)5. SWIs were registered to the MPRAGE
images, and five ROIs (caudate nucleus, putamen, globus pallidus, thalamus and
white matter) were selected from the GIF parcellations (Figure 1). In order to enable a
cross-vendor comparison, the mean SWI signal intensity within each ROI was
normalised using the lateral ventricle ROI as a reference region. Statistical significances between vendors for ROI selections were calculated using repeated measure anova
(P<0.05).Results
Overall there was no significant difference
between normalised SWI signal intensity in the caudate nucleus, putamen, globus
pallidus, thalamus (Figure 2). Figure 3 shows representative Phase and
susceptibility weighted images obtained by different SWI sequences. However there
was a significant difference in mean SWI signal intensity in WM (Figure 2).Conclusion
In summary,
susceptibility weighted imaging is a technique of high potential to measure
changes in iron content and visualise microbleed and small veins in human
brain. Based on mean SWI intensity for ROIs presented in Figure 2, the susceptibility
weighted images are comparable through different vendors. Our results show
that SWI values can be exchanged between vendors and encourage
further standardization of SWI implementation among vendors.
This
is an ongoing study and there will be further assessment including quantitative susceptibility mapping with possibility of increasing number of subjects.
Acknowledgements
"We are grateful to the Wolfson Foundation and the Epilepsy Society for supporting the Epilepsy Society MRI scanner."References
1-Haacke EM,
Xu Y,
Cheng YC,
Reichenbach
JR. Susceptibility weighted imaging (SWI). Magn Reson Med. 2004
Sep;52(3):612-8.
2-Quinn
MP, Gati JS, Klass en LM, Lin AW, Bird JR, Leung SE, et al. Comparison of multiecho postprocessing schemes for SWI with use
of linear and nonlinear mask functions. AJNR Am J Neuroradiol
(2013) 34.10.3174/ajnr.A3584
3-Denk C, Rauscher A.
Susceptibility weighted imaging with multiple echoes. J Magn Reson Imaging. 2010 Jan;31(1):185-91. doi: 10.1002/jmri.21995.
4-Lin PY, Chao TC, Wu ML.
Quantitative susceptibility mapping of human brain at 3T: a multisite
reproducibility study. AJNR Am J
Neuroradiol. 2015
Mar;36(3):467-74. doi: 10.3174/ajnr.A4137 5-M. Jorge Cardoso, Marc Modat, Robin Wolz, Andrew Melbourne, David Cash, Daniel Rueckert, and Sebastien Ourselin.Geodesic Information Flows: Spatially-Variant Graphs and Their Application to Segmentation and Fusion. IEEE Transactions on Medical Imaging, 34(9), 1976-1988. (2015).